NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer

CompletedNA

Sponsor: Mayo Clinic

Conditions: Breast Carcinoma

Interventions: QT Ultrasound Breast Scanner, Questionnaire Administration

Countries: United States

This clinical trial compares the use of quantitative transmission imaging (QTI) to standard of care MRI as a supplemental screening tool for patients with a high lifetime risk of breast cancer. QTI is a single 3D ultrasound test intended to be used as an initial evaluation method for asymptomatic women identified with above-average risk for developing breast cancer. Using QTI may be an effective supplemental screening tool, compared to MRI for patients with a high lifetime risk of breast cancer.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Women 18+ years of age
* High lifetime risk of breast cancer as determined by a risk assessment tool such a Tyrer-Cuzick model
* Clinical ordered screening MRI.

  * MRI and QTI performed within 30 days of each other
* Breasts that will fit in the quantitate transmission (QT) Ultrasound Breast Scanner (e.g. bra cup size less than DDD)

Exclusion Criteria:

* Pregnant patients
* Lactating patients
* Patients with open wounds or discharge
* Patients \< 18 years of age
* Patients who are \> 350 lbs
* Patients who are unable to lay prone for \>15 minutes

Locations (1)

Rochester, Minnesota, United States